Hello Heart is a digital therapeutics company that focuses on heart health, the #1 cause of death for men and women in the US.
Hello Heart’s mission is to empower people to understand and improve their health using technology.
Hello Heart was founded in Israel in 2013 by Maayan Cohen and Ziv Meltzer. The company is headquartered in Menlo Park, California and Tel Aviv, Israel.
Hello Heart flagship solution is an FDA-cleared blood pressure monitor coupled with an app. The app empowers people to track their blood pressure, pulse, medications, weight and activity using AI-based technology.
Hello Heart's app provides real-time alerts to extremely high readings and encourages users to reach out to their physicians and healthcare professionals to catch risk in time.
Hello Heart intends to deepen the use cases of their artificial intelligence (AI) engines to help manage heart health, which will include enhancing lifestyle digital coaching modules, and adding whole heart health functionality such as deeper medication tracking capabilities, cholesterol tracking and hyperlipidemia digital coaching.
Hello Heart is backed by IVP, Stripes, Khosla Ventures, BlueRun Ventures, Maven Ventures, Resolute Ventures, and others. The company raised $70M in Series D round on May 02, 2022. This brings Hello Heart's total funding to $138.2M to date.